Showing 71 - 80 of 7,772
Econometric analysis of 113 online pharmacies finds that quality of service is higher for online pharmacies with insurance coverage and those that also run conventional pharmacies and have been open for a longer time. The significant impact of insurance coverage suggests that provision of...
Persistent link: https://www.econbiz.de/10014085680
This paper argues that drugs are expensive not because of a lack of competition among research-based pharmaceutical companies, but because of a lack of competition in the drug approval process. Lack of competition in the drug approval process has led to exceedingly high drug development costs....
Persistent link: https://www.econbiz.de/10004995401
Using individual level-data, the paper uncovers patient and drug characteristics that determine the probability of using the original patented products despite the presence of generic substitutes in the Czech Republic in the period 2009-2013. Our results reveal different behavioral patterns for...
Persistent link: https://www.econbiz.de/10011432132
The model of regulations on Traditional Chinese Medicine (TCM) in Taiwan is often categorized as “equalization” or “non-discriminatory,” though in reality the TCM practice is unequally regulated or even marginalized. The thesis of this Article is that medical licensing law in Taiwan...
Persistent link: https://www.econbiz.de/10013000778
Persistent link: https://www.econbiz.de/10012933672
government's legislative powers. With trials and marketing of compounds and pharmaceuticals carried out in different countries …
Persistent link: https://www.econbiz.de/10014213862
This Article is part one of a two-part series that seeks to deter unethical clinical drug trials in developing nations by preventing products developed unethically from gaining market approval. In particular, this Article argues for a combination of soft-law techniques, including more robust and...
Persistent link: https://www.econbiz.de/10014218714
Imitation is the sincerest form of flattery; that is, unless the imitation is of a product produced by a multi billion-dollar industry. Then, imitation has the potential to involve intellectual property litigation. For the pharmaceutical industry, the majority of intellectual property litigation...
Persistent link: https://www.econbiz.de/10014161252
proliferate, the costs of pharmaceuticals take increasingly larger shares of most countries' health service spending, and …
Persistent link: https://www.econbiz.de/10014055619
Considerable resources have been spent on estimating the size of populations of people who use drugs (PWUD) and people who inject drugs (PWID) in Africa. Precise estimates are elusive, not least because of stigma and criminalization faced by these populations. Bio-behavioral surveys focused on...
Persistent link: https://www.econbiz.de/10014480876